ASIA News

Also, digital gynaecology clinic Pinky Promise in India has raised $1 million in pre-seed funding.

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.

It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.